~9 spots leftby Jan 2026

Targeted Injection Settings for HIV Prevention

Recruiting in Palo Alto (17 mi)
Carl Latkin | Johns Hopkins | Bloomberg ...
Overseen byCarl Latkin, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Johns Hopkins Bloomberg School of Public Health
No Placebo Group

Trial Summary

What is the purpose of this trial?

Conduct a study of people who use drugs (PWUD) perceptions of and access to COVID-19 vaccines as well as reasons for vaccine hesitancy/barriers

Research Team

Carl Latkin | Johns Hopkins | Bloomberg ...

Carl Latkin, PhD

Principal Investigator

Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria

This trial is for people who have used opioids in the last two weeks. It's focused on understanding their views on COVID-19 vaccines, access to these vaccines, and what might be stopping them from getting vaccinated. There are no specific exclusion criteria listed.

Inclusion Criteria

Opioid use in prior 2 weeks

Exclusion Criteria

Not applicable.

Treatment Details

Interventions

  • Intervention test (Behavioral Intervention)
Trial OverviewThe study isn't testing a new drug or treatment. Instead, it's analyzing how people who inject drugs feel about COVID-19 vaccines and identifying any obstacles they face in getting vaccinated.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
behavioral intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Johns Hopkins Bloomberg School of Public HealthBaltimore, MD
Loading ...

Who Is Running the Clinical Trial?

Johns Hopkins Bloomberg School of Public Health

Lead Sponsor

Trials
441
Patients Recruited
2,157,000+

National Institutes of Health (NIH)

Collaborator

Trials
2896
Patients Recruited
8,053,000+